Clinical trial
Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation
NCT05508841 is registered in ClinicalTrials.gov with Baycrest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation
- Lead sponsor
- Baycrest
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- December 31, 2026
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.